Search Results
8 protocol(s) meet the specified criteria
Non-Randomized, Open-Label, Phase II Study of Trametinib in Patients with Unresectable or Metastatic Epithelioid Hemangioendothelioma

Multicenter, Phase I, Open-Label Study of DCC-2618 to Assess Safety, Tolerability, Efficacy, and Pharmacokinetics in Patients with Advanced Malignancies

Randomlzed Phase III Trial of TRC105 and Pazopanib versus Pazop Anib Alone in Patients with Advanced Angiosarcoma (TAPPAS)

73233Not Open *
Prospective, Multicenter, Randomized, Open-Label, Active-Controlled, Two-Parallel Groups, Phase III Study to Compare the Efficacy and Safety of Masitinib to Sunitinib in Patients with Gastrointestinal Stromal Tumor after Progression with Imatinib

Phase I/IB Study of MGCD516 in Patients with Advanced Solid Tumor Malignancies

Phase I/IIA Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of PLX8394 in Patients with Advanced, Unresectable Solid Tumors

Phase I/II, Open-Label, Multicenter Study of the Safety and Efficacy of LAG525 Single Agent and in Combination with PDR001 Administered to Patients with Advanced Malignancies

Phase I/II Trial of Pre-Operative Image Guided Intensity Modulated Proton Radiation Therapy (IMPT) with Simultaneously Integrated Boost to the High Risk Margin for Retroperitoneal Sarcomas (Phase II Only)